Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Molecular mechanism of Cr(VI)-induced carcinogenesis.

Authors
Shi-X; Castranova-V; Vallyathan-V
Source
Metal ions in Biology and Medicine, 2000, J. A. Cantano, P. Collery, G. Vernet, R. B. Finkelman, H. Gibb, J. C. Etienna, eds., Paris, France: John Libbey Eurotext, 2000 Jan; 6:110-112
Link
NIOSHTIC No.
20021064
Abstract
We hypothesize that reduction of Cr(VI) to its low oxidation states, Cr(V) and Cr(IV), is an important step in the mechanism of Cr(VI)-induced carcinogenesis. These chromium intermediates are able to generate reactive oxygen species (ROS), which initiate Cr(VI)-induced carcinogenesis. Through free radical reactions, Cr(VI) can activate multiple carcinogenic processes. (1) Cr(VI) causes activation of nuclear transcription factor kappa B (NF -KB). Among ROS, hydroxyl radicals (OH) are responsible for Cr(VI)-induced NF-KB activation. (2) Cr(VI) is able to activate activator protein-1 (AP-l). (3) Cr(VI) causes p53 activation and OH radicals function as messengers for the activation of this tumor suppressor protein. (4) Cr(VI) is capable of inducing apoptosis via both p53 and ROS-mediated reactions. (5) Cr(VI) causes over-expression of oncogenes (jun-B and raf), up-regulation of antioxidants (glutathione peroxidase), activation of certain enzymes involved in mitogen-activated protein kinase (MAP kinase) signal pathways (MAPKAP kinase), stimulation of enzymes involved in cell cycle control and checkpoint mechanisms (checkpoint suppressor 1), and activation of enzymes responsible for Cr(VI) reduction, such as NAD(P)H dependent dihydrolipoamide dehydrogenase. Cr(VI)-containing compounds are considered to be well established carcinogens (1). They are potent inducers of tumors in experimental animals and active agents in causing DNA damage such as DNA strand breakage. We have hypothesized that reduction of Cr(VI) to its low oxidation states, Cr(V) and Cr(IV), is an important step (2). These chromium intermediates are able to generate ROS, which initiate Cr(VI)-induced carcinogenesis. This article summarizes our studies on Cr(VI) reduction and related free radical generation and the role of free radical reactions in various potential mechanisms for the initiation of carcinogenesis induced by this metal.
Keywords
Carcinogenesis; Carcinogens; Carcinogenicity; Chromium-compounds; Free-radicals; Oncogenesis; Oncogenic-agents; Oncogenicity; Antioxidants; Metals; Free-radical-generation; Laboratory-animals; Animals; Animal-studies
CAS No.
7440-47-3
Publication Date
20000101
Document Type
Abstract; Conference/Symposia Proceedings
Editors
Cantano-JA; Collery-P; Vernet-G; Finkelman-RB; Gibb-H; Etienna-JC
Fiscal Year
2000
NTIS Accession No.
NTIS Price
NIOSH Division
HELD
Source Name
Metal ions in Biology and Medicine
State
WV
TOP